| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.834 | 0.004 | 0.834 | Tumour necrosis factor alpha release inhibitor | 0.768 0.004 DBMET03254 0.567 0.009 DBMET03255 | ||
| 0.792 | 0.003 | 0.792 | Interleukin agonist | 0.686 0.004 DBMET03254 0.524 0.007 DBMET03255 | ||
| 0.769 | 0.001 | 0.769 | Interleukin 2 agonist | 0.724 0.002 DBMET03254 0.67 0.002 DBMET03255 | ||
| 0.73 | 0.005 | 0.73 | Immunomodulator | 0.629 0.009 DBMET03254 0.318 0.073 DBMET03255 | ||
| 0.543 | 0.071 | 0.574 | Antiinflammatory | 0.574 0.061 DBMET03254 | DBMET03254 | |
| 0.47 | 0.017 | 0.47 | DNA damaging | 0.391 0.031 DBMET03254 0.199 0.116 DBMET03255 | ||
| 0.456 | 0.047 | 0.468 | Calcium channel L-type activator | 0.468 0.041 DBMET03254 0.324 0.137 DBMET03255 | DBMET03254 | |
| 0.402 | 0.006 | 0.402 | Cytokine production inhibitor | 0.293 0.016 DBMET03254 0.21 0.033 DBMET03255 | ||
| 0.379 | 0.008 | 0.379 | Tumour necrosis factor antagonist | 0.265 0.026 DBMET03254 | ||
| 0.375 | 0.004 | 0.375 | Interleukin 12 antagonist | 0.278 0.004 DBMET03254 0.123 0.027 DBMET03255 | ||
| 0.384 | 0.024 | 0.384 | DNA synthesis inhibitor | 0.367 0.027 DBMET03254 0.215 0.101 DBMET03255 | ||
| 0.406 | 0.052 | 0.406 | Angiogenesis inhibitor | 0.38 0.06 DBMET03254 0.196 0.174 DBMET03255 | ||
| 0.411 | 0.061 | 0.429 | Transcription factor NF kappa B inhibitor | 0.429 0.057 DBMET03254 | DBMET03254 | |
| 0.411 | 0.091 | 0.411 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.273 0.251 DBMET03254 0.367 0.133 DBMET03255 | ||
| 0.348 | 0.032 | 0.348 | Psychostimulant | 0.216 0.072 DBMET03254 | ||
| 0.309 | 0.014 | 0.309 | Interleukin 6 antagonist | 0.213 0.034 DBMET03254 | ||
| 0.335 | 0.043 | 0.335 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.299 0.065 DBMET03254 | ||
| 0.29 | 0.023 | 0.29 | Lipocortins synthesis antagonist | 0.27 0.028 DBMET03254 | ||
| 0.264 | 0.005 | 0.264 | Interleukin 2 antagonist | 0.207 0.007 DBMET03254 0.119 0.047 DBMET03255 | ||
| 0.348 | 0.094 | 0.348 | MAP kinase kinase 6 inhibitor | 0.279 0.156 DBMET03254 | ||
| 0.253 | 0.005 | 0.253 | 5 Hydroxytryptamine 3A agonist | 0.204 0.014 DBMET03254 0.099 0.077 DBMET03255 | ||
| 0.254 | 0.016 | 0.254 | Alkylator | 0.195 0.028 DBMET03254 0.109 0.079 DBMET03255 | ||
| 0.276 | 0.04 | 0.276 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.242 0.077 DBMET03254 | ||
| 0.316 | 0.089 | 0.418 | Vasodilator, peripheral | 0.418 0.05 DBMET03254 0.198 0.178 DBMET03255 | DBMET03254 | |
| 0.229 | 0.01 | 0.229 | Polo-like kinase-4 inhibitor | 0.186 0.019 DBMET03254 0.117 0.059 DBMET03255 | ||
| 0.236 | 0.023 | 0.293 | Acetylcholine antagonist | 0.293 0.014 DBMET03254 | DBMET03254 | |
| 0.233 | 0.024 | 0.291 | Cholinergic antagonist | 0.291 0.015 DBMET03254 | DBMET03254 | |
| 0.264 | 0.064 | 0.264 | Angiogenesis stimulant | 0.233 0.078 DBMET03254 | ||
| 0.2 | 0.005 | 0.2 | Poly(ADP-ribose) polymerase inhibitor | 0.077 0.011 DBMET03254 0.046 0.029 DBMET03255 | ||
| 0.238 | 0.056 | 0.295 | Anesthetic general | 0.295 0.034 DBMET03254 | DBMET03254 | |
| 0.194 | 0.02 | 0.194 | Nav1.1 sodium channel blocker | 0.165 0.028 DBMET03254 0.118 0.05 DBMET03255 | ||
| 0.177 | 0.005 | 0.177 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.064 0.012 DBMET03254 0.037 0.027 DBMET03255 | ||
| 0.188 | 0.017 | 0.195 | Antineoplastic alkaloid | 0.195 0.015 DBMET03254 0.175 0.021 DBMET03255 | DBMET03254 | |
| 0.283 | 0.127 | 0.288 | GABA C receptor rho-3 antagonist | 0.288 0.124 DBMET03254 | DBMET03254 | |
| 0.186 | 0.03 | 0.186 | Topoisomerase I inhibitor | 0.185 0.03 DBMET03254 0.093 0.076 DBMET03255 | ||
| 0.25 | 0.096 | 0.25 | Insulysin inhibitor | 0.241 0.105 DBMET03254 0.201 0.155 DBMET03255 | ||
| 0.168 | 0.027 | 0.168 | Nav1.4 sodium channel blocker | 0.164 0.028 DBMET03254 0.106 0.067 DBMET03255 | ||
| 0.148 | 0.011 | 0.148 | Phosphodiesterase XI inhibitor | 0.119 0.02 DBMET03254 0.108 0.026 DBMET03255 | ||
| 0.148 | 0.011 | 0.148 | Phosphodiesterase 11A inhibitor | 0.119 0.02 DBMET03254 0.108 0.026 DBMET03255 | ||
| 0.146 | 0.011 | 0.146 | Phosphodiesterase 6D inhibitor | 0.143 0.012 DBMET03254 0.105 0.043 DBMET03255 | ||
| 0.164 | 0.033 | 0.164 | Alpha 2b adrenoreceptor antagonist | 0.109 0.067 DBMET03254 | ||
| 0.301 | 0.172 | 0.378 | Apoptosis agonist | 0.378 0.124 DBMET03254 | DBMET03254 | |
| 0.213 | 0.089 | 0.213 | MAP kinase kinase 3 inhibitor | |||
| 0.212 | 0.09 | 0.322 | MAP-kinase-activated kinase 5 inhibitor | 0.322 0.019 DBMET03254 | DBMET03254 | |
| 0.15 | 0.029 | 0.15 | Alpha 1 adrenoreceptor antagonist | |||
| 0.131 | 0.018 | 0.131 | Cyclin B3 inhibitor | 0.111 0.024 DBMET03254 | ||
| 0.157 | 0.046 | 0.169 | Glutamate receptor antagonist | 0.108 0.087 DBMET03254 0.169 0.039 DBMET03255 | DBMET03255 | |
| 0.268 | 0.16 | 0.374 | Antibacterial | 0.374 0.089 DBMET03254 | DBMET03254 | |
| 0.166 | 0.061 | 0.218 | Acetylcholine M1 receptor antagonist | 0.218 0.035 DBMET03254 | DBMET03254 | |
| 0.124 | 0.022 | 0.125 | Somatostatin 1 agonist | 0.125 0.021 DBMET03254 | DBMET03254 | |
| 0.247 | 0.151 | 0.247 | Calcium channel activator | 0.224 0.179 DBMET03254 | ||
| 0.134 | 0.042 | 0.134 | Alpha adrenoreceptor antagonist | |||
| 0.138 | 0.048 | 0.193 | DNA intercalator | 0.193 0.028 DBMET03254 0.105 0.069 DBMET03255 | DBMET03254 | |
| 0.123 | 0.034 | 0.123 | NMDA receptor antagonist | 0.111 0.04 DBMET03254 0.084 0.061 DBMET03255 | ||
| 0.105 | 0.016 | 0.105 | Histone deacetylase inhibitor | 0.083 0.028 DBMET03254 0.058 0.057 DBMET03255 | ||
| 0.102 | 0.014 | 0.102 | CDK4/cyclin D1 inhibitor | 0.093 0.017 DBMET03254 | ||
| 0.195 | 0.108 | 0.258 | Vasodilator | 0.258 0.065 DBMET03254 | DBMET03254 | |
| 0.18 | 0.094 | 0.18 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.124 | 0.039 | 0.124 | Insulin receptor antagonist | |||
| 0.101 | 0.017 | 0.101 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.112 | 0.028 | 0.112 | Factor XII inhibitor | 0.11 0.029 DBMET03254 | ||
| 0.098 | 0.016 | 0.098 | 5 Hydroxytryptamine 3 agonist | 0.064 0.043 DBMET03254 | ||
| 0.126 | 0.046 | 0.126 | Alpha 2c adrenoreceptor antagonist | |||
| 0.112 | 0.033 | 0.112 | Acetylcholine nicotinic antagonist | |||
| 0.131 | 0.057 | 0.173 | Acetylcholine muscarinic antagonist | 0.173 0.033 DBMET03254 | DBMET03254 | |
| 0.183 | 0.11 | 0.183 | ErbB-1 antagonist | 0.166 0.141 DBMET03254 | ||
| 0.233 | 0.163 | 0.233 | Immunosuppressant | 0.209 0.187 DBMET03254 | ||
| 0.093 | 0.025 | 0.093 | Phosphodiesterase VI inhibitor | 0.087 0.032 DBMET03254 | ||
| 0.1 | 0.032 | 0.1 | NMDA 2 receptor antagonist | 0.07 0.051 DBMET03254 | ||
| 0.171 | 0.103 | 0.218 | Interleukin antagonist | 0.218 0.075 DBMET03254 | DBMET03254 | |
| 0.086 | 0.019 | 0.086 | CDK4/cyclin D inhibitor | 0.072 0.025 DBMET03254 | ||
| 0.101 | 0.035 | 0.101 | Hematopoietic | 0.095 0.042 DBMET03254 0.079 0.076 DBMET03255 | ||
| 0.155 | 0.09 | 0.164 | Neurotensin receptor agonist | 0.164 0.073 DBMET03254 | DBMET03254 | |
| 0.097 | 0.036 | 0.097 | Alpha 1b adrenoreceptor antagonist | |||
| 0.108 | 0.048 | 0.109 | Electrolyte absorption antagonist | 0.091 0.073 DBMET03254 0.109 0.046 DBMET03255 | DBMET03255 | |
| 0.08 | 0.024 | 0.08 | Protein kinase C eta inhibitor | 0.06 0.034 DBMET03254 | ||
| 0.162 | 0.108 | 0.162 | MAP kinase kinase 5 inhibitor | |||
| 0.086 | 0.032 | 0.086 | Cyclin-dependent kinase 4 inhibitor | 0.067 0.044 DBMET03254 | ||
| 0.097 | 0.044 | 0.097 | Bromodomain-containing protein 2 inhibitor | |||
| 0.091 | 0.04 | 0.091 | Alpha 1a adrenoreceptor antagonist | |||
| 0.067 | 0.016 | 0.067 | Antiviral (Hepatitis D) | 0.055 0.029 DBMET03254 | ||
| 0.081 | 0.03 | 0.081 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.116 | 0.068 | 0.116 | Proteasome inhibitor | |||
| 0.07 | 0.024 | 0.07 | Bromodomain-containing protein 4 inhibitor | |||
| 0.058 | 0.013 | 0.058 | Nicotinic receptor beta4 subunit antagonist | 0.052 0.015 DBMET03254 | ||
| 0.074 | 0.03 | 0.074 | NMDA 2C receptor antagonist | |||
| 0.07 | 0.027 | 0.07 | Potassium channel (Ca-activated) blocker | |||
| 0.079 | 0.038 | 0.079 | Neuronal nicotinic receptor antagonist | |||
| 0.067 | 0.026 | 0.067 | NMDA 2B receptor antagonist | 0.052 0.04 DBMET03254 | ||
| 0.076 | 0.037 | 0.076 | Protein kinase C alpha inhibitor | 0.075 0.038 DBMET03254 | ||
| 0.051 | 0.014 | 0.051 | Vasopressin 2 antagonist | 0.033 0.022 DBMET03254 | ||
| 0.102 | 0.065 | 0.111 | GABA C receptor agonist | 0.111 0.056 DBMET03254 | DBMET03254 | |
| 0.19 | 0.155 | 0.227 | Tyrosine 3 hydroxylase inhibitor | 0.227 0.094 DBMET03254 | DBMET03254 | |
| 0.048 | 0.014 | 0.048 | Histone deacetylase class IV inhibitor | 0.039 0.017 DBMET03254 0.047 0.014 DBMET03255 | ||
| 0.048 | 0.014 | 0.048 | Histone deacetylase 11 inhibitor | 0.039 0.017 DBMET03254 0.047 0.014 DBMET03255 | ||
| 0.041 | 0.008 | 0.041 | Protein kinase C beta I inhibitor | 0.038 0.012 DBMET03254 | ||
| 0.065 | 0.033 | 0.065 | Prolactin release inhibitor | |||
| 0.042 | 0.01 | 0.042 | Protein kinase C beta II inhibitor | 0.038 0.013 DBMET03254 | ||
| 0.037 | 0.005 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.005 DBMET03254 0.027 0.025 DBMET03255 | DBMET03254 | |
| 0.105 | 0.074 | 0.105 | Glycogen synthase kinase-3 inhibitor | |||
| 0.097 | 0.069 | 0.097 | mTOR complex 1 inhibitor | |||
| 0.064 | 0.037 | 0.081 | Acetylcholine M5 receptor antagonist | 0.081 0.023 DBMET03254 | DBMET03254 | |
| 0.043 | 0.016 | 0.043 | Somatostatin 5 agonist | 0.037 0.021 DBMET03254 | ||
| 0.039 | 0.015 | 0.055 | AMPA 2 receptor antagonist | 0.034 0.018 DBMET03254 0.055 0.01 DBMET03255 | DBMET03255 | |
| 0.034 | 0.012 | 0.04 | Kainate receptor 4 antagonist | 0.028 0.015 DBMET03254 0.04 0.009 DBMET03255 | DBMET03255 | |
| 0.065 | 0.042 | 0.065 | 5 Hydroxytryptamine 2A agonist | |||
| 0.126 | 0.103 | 0.126 | Hemostatic | |||
| 0.192 | 0.169 | 0.202 | 5 Hydroxytryptamine uptake stimulant | 0.202 0.147 DBMET03254 | DBMET03254 | |
| 0.036 | 0.014 | 0.036 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.055 | 0.034 | 0.055 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.06 | 0.04 | 0.06 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.049 DBMET03254 | ||
| 0.042 | 0.022 | 0.044 | Histone deacetylase 9 inhibitor | 0.044 0.021 DBMET03255 | DBMET03255 | |
| 0.035 | 0.015 | 0.035 | Complement C5a chemotactic receptor antagonist | |||
| 0.047 | 0.029 | 0.047 | Phosphodiesterase 6C inhibitor | 0.045 0.036 DBMET03254 0.046 0.034 DBMET03255 | ||
| 0.162 | 0.145 | 0.186 | Immunostimulant | 0.186 0.129 DBMET03254 | DBMET03254 | |
| 0.042 | 0.024 | 0.042 | Histone deacetylase class I inhibitor | |||
| 0.039 | 0.022 | 0.039 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.035 | 0.018 | 0.041 | Histone deacetylase 10 inhibitor | 0.026 0.023 DBMET03254 0.041 0.015 DBMET03255 | DBMET03255 | |
| 0.077 | 0.063 | 0.077 | Acetylcholine M3 receptor agonist | |||
| 0.164 | 0.15 | 0.248 | Spasmolytic | 0.248 0.092 DBMET03254 | DBMET03254 | |
| 0.039 | 0.025 | 0.039 | Oxytocin antagonist | |||
| 0.091 | 0.077 | 0.091 | GABA C receptor rho-1 antagonist | |||
| 0.069 | 0.056 | 0.074 | Glycine receptor agonist | 0.074 0.047 DBMET03254 | DBMET03254 | |
| 0.085 | 0.072 | 0.085 | Polo-like kinase-1 inhibitor | |||
| 0.042 | 0.029 | 0.042 | Melanocortin 4 antagonist | |||
| 0.048 | 0.036 | 0.048 | HCV NS3/NS4A protease inhibitor | |||
| 0.046 | 0.034 | 0.046 | Melanocortin antagonist | |||
| 0.124 | 0.112 | 0.124 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.1 | 0.088 | 0.1 | Acetylcholine release stimulant | |||
| 0.033 | 0.021 | 0.036 | Histone deacetylase 4 inhibitor | 0.036 0.019 DBMET03255 | DBMET03255 | |
| 0.099 | 0.087 | 0.099 | Nav1.5 sodium channel blocker | |||
| 0.038 | 0.028 | 0.038 | 5 Hydroxytryptamine 2B agonist | |||
| 0.04 | 0.031 | 0.04 | Growth hormone release inhibitor | 0.039 0.032 DBMET03254 | ||
| 0.033 | 0.024 | 0.033 | Histone deacetylase 2 inhibitor | 0.031 0.027 DBMET03255 | ||
| 0.091 | 0.083 | 0.096 | Cyclin-dependent kinase 5 inhibitor | 0.096 0.079 DBMET03255 | DBMET03255 | |
| 0.037 | 0.029 | 0.037 | Antidiuretic hormone antagonist | |||
| 0.053 | 0.045 | 0.053 | Kallikrein 1 inhibitor | |||
| 0.081 | 0.073 | 0.081 | Triose-phosphate isomerase inhibitor | |||
| 0.016 | 0.009 | 0.016 | CC chemokine 10 receptor antagonist | |||
| 0.094 | 0.089 | 0.094 | Interleukin 1b antagonist | |||
| 0.038 | 0.033 | 0.038 | Acid-sensing ion channel blocker | |||
| 0.055 | 0.051 | 0.055 | Cyclin A1 inhibitor | |||
| 0.011 | 0.008 | 0.011 | Melatonin 5 antagonist | |||
| 0.253 | 0.25 | 0.346 | Caspase 9 stimulant | 0.269 0.23 DBMET03254 0.346 0.149 DBMET03255 | DBMET03255 | |
| 0.025 | 0.023 | 0.025 | Vasopressin 1A antagonist | |||
| 0.018 | 0.018 | 0.025 | Kainate receptor 5 antagonist | 0.025 0.012 DBMET03255 | DBMET03255 | |
| 0.015 | 0.015 | 0.016 | Kainate receptor 3 antagonist | 0.016 0.013 DBMET03255 | DBMET03255 | |
| 0.031 | 0.034 | 0.037 | Histone deacetylase 7 inhibitor | 0.037 0.026 DBMET03255 | DBMET03255 | |
| 0.031 | 0.035 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.028 DBMET03254 | DBMET03254 | |
| 0.034 | 0.039 | 0.054 | Dopamine D5 agonist | 0.054 0.015 DBMET03254 | DBMET03254 | |
| 0.06 | 0.067 | 0.066 | CXC chemokine receptor antagonist | 0.066 0.055 DBMET03254 | DBMET03254 | |
| 0.036 | 0.049 | 0.04 | DNA gyrase subunit A inhibitor | 0.04 0.037 DBMET03254 | DBMET03254 | |
| 0.075 | 0.09 | 0.089 | Prolactin inhibitor | 0.089 0.068 DBMET03254 | DBMET03254 | |
| 0.085 | 0.102 | 0.108 | Topoisomerase II inhibitor | 0.108 0.078 DBMET03254 | DBMET03254 | |
| 0.029 | 0.049 | 0.038 | Oxytocin agonist | 0.038 0.034 DBMET03254 | DBMET03254 | |
| 0.104 | 0.129 | 0.117 | Cell wall synthesis inhibitor | 0.117 0.104 DBMET03254 | DBMET03254 | |
| 0.047 | 0.072 | 0.062 | Dopamine D1 antagonist | 0.062 0.048 DBMET03254 | DBMET03254 | |
| 0.067 | 0.099 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.045 DBMET03254 | DBMET03254 | |
| 0.073 | 0.114 | 0.088 | Anabolic | 0.088 0.081 DBMET03254 | DBMET03254 | |
| 0.065 | 0.114 | 0.081 | Breast cancer-resistant protein inhibitor | 0.081 0.079 DBMET03254 | DBMET03254 | |
| 0.112 | 0.165 | 0.169 | MAP kinase kinase 2 inhibitor | 0.169 0.105 DBMET03254 | DBMET03254 | |
| 0.175 | 0.237 | 0.38 | Histamine release inhibitor | 0.38 0.086 DBMET03254 | DBMET03254 | |
| 0.076 | 0.149 | 0.177 | Alpha-N-acetylglucosaminidase inhibitor | 0.177 0.042 DBMET03255 | DBMET03255 | |
| 0.095 | 0.184 | 0.128 | Papain-like protease (SARS coronavirus) inhibitor | 0.128 0.064 DBMET03255 | DBMET03255 | |
| 0.114 | 0.205 | 0.14 | Phospholipase C inhibitor | 0.14 0.128 DBMET03254 | DBMET03254 | |
| 0.076 | 0.184 | 0.139 | Peroxidase inhibitor | 0.139 0.084 DBMET03254 | DBMET03254 | |
| 0.058 | 0.175 | 0.177 | Tubulin antagonist | 0.177 0.046 DBMET03254 | DBMET03254 | |
| 0.133 | 0.28 | 0.218 | Antithrombotic | 0.218 0.157 DBMET03254 | DBMET03254 | |
| 0.042 | 0.274 | 0.188 | DNA polymerase I inhibitor | 0.188 0.032 DBMET03255 | DBMET03255 | |
| 0.049 | 0.37 | 0.168 | Antimitotic | 0.168 0.106 DBMET03254 | DBMET03254 | |
| 0.097 | 0.453 | 0.164 | Peptidyltransferase inhibitor | 0.164 0.159 DBMET03255 | DBMET03255 | |
| 0.063 | 0.501 | 0.16 | Death-associated protein kinase 2 inhibitor | 0.16 0.084 DBMET03255 | DBMET03255 | |
| 0.009 | 0.519 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.057 DBMET03255 | DBMET03255 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |